- AIDS and the FDA: An Ethical Case for Limiting Patient Access to New Medical Therapies.Andrew F. Shorr - 1992 - IRB: Ethics & Human Research 14 (4):1.details
|
|
An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics.Ruth R. Faden, Nancy E. Kass, Steven N. Goodman, Peter Pronovost, Sean Tunis & Tom L. Beauchamp - 2013 - Hastings Center Report 43 (s1):16-27.details
|
|
Can RESEARCH and CARE Be Ethically Integrated?Emily A. Largent, Steven Joffe & Franklin G. Miller - 2011 - Hastings Center Report 41 (4):37-46.details
|
|
Scientific research is a moral duty.J. Harris - 2005 - Journal of Medical Ethics 31 (4):242-248.details
|
|
Access for the terminally ill to experimental medical innovations: A three-pronged threat.Shira Bender, Lauren Flicker & Rosamond Rhodes - 2007 - American Journal of Bioethics 7 (10):3 – 6.details
|
|
Capacity and shared decision-making in serious illness.Ronald M. Epstein & Vikki Entwistle - 2014 - In Timothy E. Quill & Franklin G. Miller (eds.), Palliative care and ethics. New York: Oxford University Press.details
|
|
The Obligation to Participate in Biomedical Research.G. Owen Schaefer, Ezekiel J. Emanuel & Alan Wertheimer - 2009 - Journal of the American Medical Association 302 (1):67-72.details
|
|
Off-trial access to experimental cancer agents for the terminally ill: balancing the needs of individuals and society.M. Chahal - 2010 - Journal of Medical Ethics 36 (6):367-370.details
|
|
Ethics of Clinical Science in a Public Health Emergency: Drug Discovery at the Bedside.Sarah Jl Edwards - 2013 - American Journal of Bioethics 13 (9):3-14.details
|
|
Why Communities and Their Goods Matter: Illustrated with the Example of Biobanks.Heather Widdows & Sean Cordell - 2011 - Public Health Ethics 4 (1):14-25.details
|
|
(1 other version)Right to Experimental Treatment: FDA New Drug Approval, Constitutional Rights, and the Public's Health.Elizabeth Weeks Leonard - 2009 - Journal of Law, Medicine and Ethics 37 (2):269-279.details
|
|
Restricted treatments, inducements, and research participation.Sarah J. L. Edwards - 2006 - Bioethics 20 (2):77–91.details
|
|
Terminal illness and access to phase 1 experimental agents, surgeries and devices: Reviewing the ethical arguments.Udo Schüklenk & Christopher Lowry - 2009 - British Medical Bulletin 89 (1):7-22.details
|
|
The Research‐Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight.Nancy E. Kass, Ruth R. Faden, Steven N. Goodman, Peter Pronovost, Sean Tunis & Tom L. Beauchamp - 2013 - Hastings Center Report 43 (s1):4-15.details
|
|
(1 other version)Right to Experimental Treatment: FDA New Drug Approval, Constitutional Rights, and the Public's Health.Elizabeth Weeks Leonard - 2009 - Journal of Law, Medicine and Ethics 37 (2):269-279.details
|
|
Is it sound public policy to let the terminally ill access experimental medical innovations?Arthur Caplan - 2007 - American Journal of Bioethics 7 (6):1 – 3.details
|
|
Innovative Surgery and the Precautionary Principle.Denise Meyerson - 2013 - Journal of Medicine and Philosophy 38 (6):jht047.details
|
|
Controversial Medical Treatment and the Right to Health Care.John Ancona Robertson - 2006 - Hastings Center Report 36 (6):15-20.details
|
|
Investigational Drugs and the Constitution.Rebecca Dresser - 2006 - Hastings Center Report 36 (6):9-10.details
|
|